What Is SUDEP in Epilepsy: Risks and Prevention

SUDEP stands for Sudden Unexpected Death in Epilepsy, and it is the leading cause of death directly related to epilepsy. It refers to the sudden, unexpected death of someone with epilepsy that cannot be explained by trauma, drowning, or another identifiable cause. Roughly 1 in 1,000 people with epilepsy die from SUDEP each year, though the risk varies significantly depending on seizure type and frequency.

How SUDEP Is Defined

For a death to be classified as SUDEP, it must meet specific criteria: the death is sudden and unexpected, occurs in someone with epilepsy, and happens in otherwise normal circumstances. There may or may not be evidence that a seizure occurred. Deaths during prolonged seizures lasting more than 30 minutes (a condition called status epilepticus) are excluded from the definition.

Doctors classify SUDEP into categories based on how much information is available. “Definite SUDEP” means the person met all the criteria and a full autopsy revealed no alternative cause of death. “Probable SUDEP” applies when the criteria are met but no autopsy was performed. There is also a “definite plus” category for cases where the autopsy found something that might have contributed to death but doesn’t fully explain it on its own.

What Happens in the Body

Most SUDEP cases follow a generalized convulsive seizure. The best evidence comes from cases that occurred during hospital monitoring, where researchers could track exactly what went wrong. In every evaluable monitored case, breathing stopped first, followed by the heart stopping. This sequence is important: it suggests that the primary failure is respiratory, not cardiac.

After a major convulsive seizure, the brain’s breathing centers can temporarily shut down, a phenomenon called postictal central apnea. During this period, oxygen levels in the blood drop sharply while carbon dioxide builds up. In most people, breathing restarts on its own. In SUDEP, it doesn’t. The prolonged oxygen deprivation then disrupts the heart’s rhythm and ability to contract, eventually leading to cardiac arrest. The entire process can unfold within minutes.

Who Is Most at Risk

The single biggest risk factor is having generalized tonic-clonic seizures, the type involving loss of consciousness and full-body convulsions. A nationwide case-control study found that experiencing even one to three of these seizures in the previous year was associated with a 22-fold increase in SUDEP risk. Having four to ten raised the risk 32-fold. Interestingly, the risk did not continue climbing beyond ten seizures per year, suggesting there may be a ceiling effect.

Other factors that increase risk include:

  • Poor medication adherence. Having nonadherence noted in a medical record was associated with nearly a threefold increase in risk.
  • Uncontrolled or drug-resistant epilepsy. People whose seizures don’t respond well to treatment face higher overall exposure to dangerous seizure events.
  • Sleeping alone. A disproportionate number of SUDEP cases happen during sleep, and the absence of someone nearby who could intervene appears to matter.

SUDEP in Children vs. Adults

Earlier estimates suggested children faced a much lower risk than adults, with reported rates around 0.22 per 1,000 epilepsy person-years in children compared to 1.2 in adults. More recent studies paint a different picture. A Swedish registry study found rates of roughly 1.1 per 1,000 in children under 16, nearly identical to the rates in older age groups. Another study found a pediatric incidence of 1.17 per 1,000, and after accounting for likely missed cases, the adjusted estimate rose to 1.45 per 1,000. The earlier gap was probably due to underreporting and fewer autopsies in children rather than a true difference in biology.

The Role of Genetics

Some people with epilepsy may carry genetic traits that make them more vulnerable. Certain gene variants affect ion channels, the tiny gates that control electrical signals in both the brain and the heart. Mutations in these genes can cause both seizure disorders and abnormal heart rhythms. For example, gene variants responsible for long QT syndrome, a condition where the heart takes too long to recharge between beats, have been found in a subset of SUDEP cases. Children with Dravet syndrome, a severe genetic epilepsy, are known to carry an elevated SUDEP risk, and molecular autopsies have confirmed pathogenic variants in the gene most commonly linked to that condition.

This overlap between heart and brain electrical systems may explain why some individuals are especially vulnerable to the breathing and heart rhythm failures that occur after a seizure.

What Reduces the Risk

The most effective strategy is seizure control, particularly reducing or eliminating generalized tonic-clonic seizures. Because these seizures carry the overwhelming majority of SUDEP risk, any treatment approach that lowers their frequency, whether medication, surgery, or dietary therapy, also lowers the chance of SUDEP.

Taking epilepsy medication consistently matters. The nearly threefold risk increase associated with nonadherence makes skipped doses one of the most avoidable risk factors. If side effects are making it hard to stick with a medication, working with a neurologist to find an alternative is far safer than stopping or skipping doses.

Nighttime supervision also appears protective. One large case-control study found that having someone present during sleep was associated with a 66% reduction in SUDEP risk, and a second smaller study found an even larger protective effect. Importantly, this benefit held up even after accounting for how well seizures were controlled, meaning it wasn’t simply that people with milder epilepsy were more likely to share a room. The evidence remains limited in quality, but the direction is consistent: having someone nearby who can reposition you, stimulate you to breathe, or call for help after a nighttime seizure may prevent the fatal cascade from progressing.

Seizure detection devices, including bed sensors and wearable monitors, are increasingly used as a substitute for in-person supervision, particularly for adults who live alone. Evidence on specific devices is still thin, but they work on the same principle: alerting someone to intervene quickly after a seizure occurs during sleep.